Temasek-backed Chinese cancer biotech firm Gracell files for $100m US IPO

Temasek-backed Chinese cancer biotech firm Gracell files for $100m US IPO

Photographer: Victor J. Blue/Bloomberg

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter